Viewpoints

Rapid diagnostic tests to support clinical trials of antibiotics – by Gian Maria Rossolini
4 Jun 2021

Rapid diagnostic tests to support clinical trials of antibiotics – by Gian Maria Rossolini

Due to the antibiotic resistance crisis that has dramatically emerged at the beginning of the new century, the past decade has seen a notable resurgence of clinical trials involving antibiotics1,2. Indeed, such a crisis prompted a remarkable effort in the discovery and development of new antibiotics active against the most problematic multidrug-resistant (MDR) pathogens such as carbapenem-resistant Enterobacterales (CRE), MDR Pseudomonas aeruginosa, carbapenem-resistant Acinetobacter baumannii (CRAb), vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA), yielding a number of novel antibiotics that variably cover these resistant pathogens3,4.

Read more
We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.